Factory Mutual Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Sell
25,400
-200
-0.8% -$136K 0.15% 130
2026
Q1
$19.8M Buy
25,600
+800
+3% +$612K 0.22% 111
2025
Q4
$19.1M Sell
24,800
-800
-3% -$543K 0.19% 123
2025
Q3
$14.4M Hold
25,600
0.14% 135
2025
Q2
$13.4M Buy
25,600
+13,500
+112% +$7.53M 0.15% 137
2025
Q1
$7.67M Buy
12,100
+8,200
+210% +$5.64M 0.09% 150
2024
Q4
$2.78M Buy
+3,900
New +$3.27M 0.03% 168

Other funds holding REGN

Factory Mutual Insurance's REGN Position: Q2 2026 in Review

Factory Mutual Insurance reduced its Regeneron Pharmaceuticals (REGN) stake by 0.78% in Q2 2026, selling an estimated $136K and leaving 25,400 shares worth $15.8M. The position accounts for 0.15% of the portfolio, ranked #130.

Factory Mutual Insurance first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.8M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Factory Mutual Insurance held 25,400 shares of Regeneron Pharmaceuticals worth $15.8M as of Q2 2026.
  • Factory Mutual Insurance sold 200 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $136K.
  • Regeneron Pharmaceuticals made up 0.15% of Factory Mutual Insurance's portfolio in Q2 2026, its #130 holding.
  • Factory Mutual Insurance first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Factory Mutual Insurance's Regeneron Pharmaceuticals position peaked at $19.8M in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Factory Mutual Insurance's 13F filing for Q2 2026, filed 21 Jul 2026.